schizophrenia

Schizophrenia is a long-term mental health condition that causes a range of different psychological symptoms. These include: hallucinations (hearing or seeing things that do not exist), delusions (unusual beliefs that are not based on reality and often contradict the evidence), muddled thoughts based on the hallucinations or delusions, and changes in behaviour. Doctors describe schizophrenia as a psychotic illness. This means that sometimes a person may not be able to distinguish their own thoughts and ideas from reality.

Our schizophrenia Blogs

Smoking cessation for people with severe mental illness

shutterstock_225156700

Sally Adams appraises and summarises the SCIMITAR pilot RCT, which investigates smoking cessation for people with severe mental ill health. The paper presents a highly promising bespoke intervention for smokers with bipolar disorder, psychosis or schizophrenia.

[read the full story...]

Smoking and risk of schizophrenia: new study finds a dose-response relationship

shutterstock_785405

Marcus Munafò looks at the mounting evidence about smoking and risk of schizophrenia, including a new case-control study that provides clear evidence of a prospective association between cigarette smoking and a subsequent diagnosis of schizophrenia.

[read the full story...]

Quetiapine for schizophrenia: more transparency needed in clinical trial reporting

shutterstock_122223547

Andrew Shepherd reports on a recent systematic review, meta-analysis and reappraisal of Quetiapine for schizophrenia, which concludes that Quetiapine IR has a small beneficial effect on psychotic symptoms, but also leads to weight gain and sedation.

[read the full story...]

CBTp and medication in the treatment of psychosis: summarising the best evidence

shutterstock_158430557

Clive Adams presents a summary of the latest evidence for CBTp and medication in the treatment of psychosis. This blog was published alongside Clive’s talk at the Understanding Psychosis and Schizophrenia conference in Bath on 11 June 2015

[read the full story...]

Biological markers for treatment response in first episode psychosis

shutterstock_96270467

Stephen Wood summarises a systematic review of biological markers for treatment response in first episode psychosis, which discusses a number of hot topics in this field including inflammation, infectious disease and oxidative stress.

[read the full story...]

Promoting smoking cessation in people with schizophrenia

shutterstock_276469196

Meg Fluharty summarises a recent clinical overview of smoking cessation in people with severe mental illness, which provides useful practical advice to clinicians who are trying to help service users with schizophrenia, psychosis and other conditions to quit smoking

[read the full story...]

Peer-led self-management for mental health: impressive programme, not so sure about the research

shutterstock_211261933

Lucy Simons and Chris Sampson appraise a recent evaluation of peer-led self-management training for people with severe mental illness.

[read the full story...]

The more psychotic you are, the more benefit there is in taking antipsychotics

shutterstock_122223547

John Baker reviews a recent participant-level meta-analysis of six placebo-controlled studies, which looks at the initial severity of schizophrenia and the efficacy of antipsychotics including Olanzapine, Risperidone and Amisulpride.

[read the full story...]

Do we stigmatise mental illness more as we age?

shutterstock_186330554

Raluca Lucacel writes her debut blog about an age-period-cohort analysis, which investigates how attitudes towards people with mental illness worsen during the course of life.

[read the full story...]